760958-17-6

Basic information

• Product Name: Carbamic acid, (trans-4-methoxycyclohexyl)-, 1,1-dimethylethyl ester
• CAS NO: 760958-17-6
• Molecular Formula: C12H23NO3
• Molecular Weight: 229.32
• Mol File: 760958-17-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (trans-4-methoxycyclohexyl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (trans-4-methoxycyclohexyl)-, 1,1-dimethylethyl ester(760958-17-6)
• EPA Substance Registry System: Carbamic acid, (trans-4-methoxycyclohexyl)-, 1,1-dimethylethyl ester(760958-17-6)

Safety Data

• Hazardous Substances Data: 760958-17-6(Hazardous Substances Data)

Upstream product

• 420-37-1 trimethoxonium tetrafluoroborate 
• 111300-06-2 trans-tert-butyl 4-hydroxycyclohexylcarbamate 
• 74-88-4 methyl iodide 

Downstream Products

• 1214254-89-3 2-[(E)-2-(6,7-difluoro-3-methylquinoxalin-2-yl)vinyl]-N-(trans-4-methoxycyclohexyl)-6-pyrrolidin-1-ylpyrimidin-4-amine 
• 1214254-88-2 diethyl {[4-(trans-4-methoxycyclohexylamino)-6-pyrrolidin-1-ylpyrimidin-2-yl]methyl}phosphonate 
• 1214254-87-1 diethyl {[4-chloro-6-(trans-4-methoxycyclohexylamino)pyrimidin-2-yl]methyl}phosphonate 
• 1214253-93-6 2-[(E)-2-(6-fluoro-3-methylquinoxalin-2-yl)vinyl]-N-(trans-4-methoxycyclohexyl)-6-pyrrolidin-1-ylpyrimidin-4-amine 
• 61367-41-7 (1r,4r)-4-methoxycyclohexan-1-amine hydrochloride 

Relevant articles and documents

Compounds and methods of use

Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein X1, X2, X3, X4, Y, A, L1, L2, R1, R2, R5, m and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

BENZIMIDAZOLYL-METHYL UREA DERIVATIVES AS ALX RECEPTOR AGONISTS

The present invention relates to benzimidazolyl-methyl urea derivatives of formula (I), wherein n, D, E, R1, R2, R3, R4, R6, R7, R8 and R9 are as defined in the description, their preparation and their use as pharmaceutically active compounds.

BRADYKININ 1 RECEPTOR ANTAGONISTS

The invention encompasses novel compounds and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for treatment of diseases mediated by B1 bradykinin receptor.